Cargando…

Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression

Oral leukoplakia is the most common oral potentially malignant disorder with a malignant transformation rate into oral squamous cell carcinoma of 1–3% annually. The presence and grade of World Health Organization defined dysplasia is an important histological marker to assess the risk for malignant...

Descripción completa

Detalles Bibliográficos
Autores principales: Wils, Leon J., Poell, Jos B., Evren, Ilkay, Koopman, Marit S., Brouns, Elisabeth R. E. A., de Visscher, Jan G. A. M., Brakenhoff, Ruud H., Bloemena, Elisabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280084/
https://www.ncbi.nlm.nih.gov/pubmed/31896811
http://dx.doi.org/10.1038/s41379-019-0444-0
_version_ 1783543674709213184
author Wils, Leon J.
Poell, Jos B.
Evren, Ilkay
Koopman, Marit S.
Brouns, Elisabeth R. E. A.
de Visscher, Jan G. A. M.
Brakenhoff, Ruud H.
Bloemena, Elisabeth
author_facet Wils, Leon J.
Poell, Jos B.
Evren, Ilkay
Koopman, Marit S.
Brouns, Elisabeth R. E. A.
de Visscher, Jan G. A. M.
Brakenhoff, Ruud H.
Bloemena, Elisabeth
author_sort Wils, Leon J.
collection PubMed
description Oral leukoplakia is the most common oral potentially malignant disorder with a malignant transformation rate into oral squamous cell carcinoma of 1–3% annually. The presence and grade of World Health Organization defined dysplasia is an important histological marker to assess the risk for malignant transformation, but is not sufficiently accurate to personalize treatment and surveillance. Differentiated dysplasia, known from differentiated vulvar intraepithelial neoplasia, is hitherto not used in oral dysplasia grading. We hypothesized that assessing differentiated dysplasia besides World Health Organization defined (classic) dysplasia will improve risk assessment of malignant transformation of oral leukoplakia. We investigated a retrospective cohort consisting of 84 oral leukoplakia patients. Biopsies were assessed for dysplasia presence and grade, and the expression of keratins 13 (CK13) and 17, known to be dysregulated in dysplastic vulvar mucosa. In dysplastic oral lesions, differentiated dysplasia is as common as classic dysplasia. In 25 out of 84 (30%) patients, squamous cell carcinoma of the upper aerodigestive tract developed during follow-up. Considering only classic dysplasia, 11 out of 56 (20%) patients with nondysplastic lesions progressed. With the incorporation of differentiated dysplasia, only 2 out of 30 (7%) patients with nondysplastic lesions progressed. The risk of progression increased from 3.26 (Hazard ratio, p = 0.002) when only classic dysplasia is considered to 7.43 (Hazard ratio, p = 0.001) when classic and differentiated dysplasia are combined. Loss of CK13, combined with presence of dysplasia, is associated with greater risk of malignant progression (p = 0.006). This study demonstrates that differentiated dysplasia should be recognized as a separate type of dysplasia in the oral mucosa and that its distinction from classic dysplasia is of pathological and clinical significance since it is a strong (co)prognostic histopathological marker for oral malignant transformation. In oral lesions without dysplasia and retained CK13 staining the risk for progression is very low.
format Online
Article
Text
id pubmed-7280084
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group US
record_format MEDLINE/PubMed
spelling pubmed-72800842020-06-15 Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression Wils, Leon J. Poell, Jos B. Evren, Ilkay Koopman, Marit S. Brouns, Elisabeth R. E. A. de Visscher, Jan G. A. M. Brakenhoff, Ruud H. Bloemena, Elisabeth Mod Pathol Article Oral leukoplakia is the most common oral potentially malignant disorder with a malignant transformation rate into oral squamous cell carcinoma of 1–3% annually. The presence and grade of World Health Organization defined dysplasia is an important histological marker to assess the risk for malignant transformation, but is not sufficiently accurate to personalize treatment and surveillance. Differentiated dysplasia, known from differentiated vulvar intraepithelial neoplasia, is hitherto not used in oral dysplasia grading. We hypothesized that assessing differentiated dysplasia besides World Health Organization defined (classic) dysplasia will improve risk assessment of malignant transformation of oral leukoplakia. We investigated a retrospective cohort consisting of 84 oral leukoplakia patients. Biopsies were assessed for dysplasia presence and grade, and the expression of keratins 13 (CK13) and 17, known to be dysregulated in dysplastic vulvar mucosa. In dysplastic oral lesions, differentiated dysplasia is as common as classic dysplasia. In 25 out of 84 (30%) patients, squamous cell carcinoma of the upper aerodigestive tract developed during follow-up. Considering only classic dysplasia, 11 out of 56 (20%) patients with nondysplastic lesions progressed. With the incorporation of differentiated dysplasia, only 2 out of 30 (7%) patients with nondysplastic lesions progressed. The risk of progression increased from 3.26 (Hazard ratio, p = 0.002) when only classic dysplasia is considered to 7.43 (Hazard ratio, p = 0.001) when classic and differentiated dysplasia are combined. Loss of CK13, combined with presence of dysplasia, is associated with greater risk of malignant progression (p = 0.006). This study demonstrates that differentiated dysplasia should be recognized as a separate type of dysplasia in the oral mucosa and that its distinction from classic dysplasia is of pathological and clinical significance since it is a strong (co)prognostic histopathological marker for oral malignant transformation. In oral lesions without dysplasia and retained CK13 staining the risk for progression is very low. Nature Publishing Group US 2020-01-02 2020 /pmc/articles/PMC7280084/ /pubmed/31896811 http://dx.doi.org/10.1038/s41379-019-0444-0 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Wils, Leon J.
Poell, Jos B.
Evren, Ilkay
Koopman, Marit S.
Brouns, Elisabeth R. E. A.
de Visscher, Jan G. A. M.
Brakenhoff, Ruud H.
Bloemena, Elisabeth
Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression
title Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression
title_full Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression
title_fullStr Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression
title_full_unstemmed Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression
title_short Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression
title_sort incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7280084/
https://www.ncbi.nlm.nih.gov/pubmed/31896811
http://dx.doi.org/10.1038/s41379-019-0444-0
work_keys_str_mv AT wilsleonj incorporationofdifferentiateddysplasiaimprovespredictionoforalleukoplakiaatincreasedriskofmalignantprogression
AT poelljosb incorporationofdifferentiateddysplasiaimprovespredictionoforalleukoplakiaatincreasedriskofmalignantprogression
AT evrenilkay incorporationofdifferentiateddysplasiaimprovespredictionoforalleukoplakiaatincreasedriskofmalignantprogression
AT koopmanmarits incorporationofdifferentiateddysplasiaimprovespredictionoforalleukoplakiaatincreasedriskofmalignantprogression
AT brounselisabethrea incorporationofdifferentiateddysplasiaimprovespredictionoforalleukoplakiaatincreasedriskofmalignantprogression
AT devisscherjangam incorporationofdifferentiateddysplasiaimprovespredictionoforalleukoplakiaatincreasedriskofmalignantprogression
AT brakenhoffruudh incorporationofdifferentiateddysplasiaimprovespredictionoforalleukoplakiaatincreasedriskofmalignantprogression
AT bloemenaelisabeth incorporationofdifferentiateddysplasiaimprovespredictionoforalleukoplakiaatincreasedriskofmalignantprogression